Search Results - "The Annals of pharmacotherapy"

Cost of Prescription Drug–Related Morbidity and Mortality by Watanabe, Jonathan H., McInnis, Terry, Hirsch, Jan D.

“…Background: Public attention and recent US Congressional activity has intensified focus on escalating medication prices. However, the actual cost of medication…”
Get full text

Balanced Crystalloids Versus Saline in Critically Ill Adults: A Systematic Review and Meta-analysis by Hammond, Drayton A., Lam, Simon W., Rech, Megan A., Smith, Melanie N., Westrick, Jennifer, Trivedi, Abhaya P., Balk, Robert A.

“…Background: The optimal resuscitative fluid remains controversial. Objective: To assess the association between crystalloid fluid and outcomes in critically…”
Get full text

Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation by Kido, Kazuhiko, Ngorsuraches, Surachat

“…Background: The International Society of Thrombosis and Haemostasis recommends avoiding direct oral anticoagulants (DOACs) in morbidly obese patients with a…”
Get full text

Prevalence and Nature of Medication Administration Errors in Health Care Settings: A Systematic Review of Direct Observational Evidence by Keers, Richard N, Williams, Steven D, Cooke, Jonathan, Ashcroft, Darren M

“…OBJECTIVE: To systematically review empirical evidence on the prevalence and nature of medication administration errors (MAEs) in health care settings. DATA…”
Get full text

The Continuum of Pharmacist Prescriptive Authority by Adams, Alex J., Weaver, Krystalyn K.

“…Recently momentum has been building behind pharmacist prescriptive authority for certain products such as oral contraceptives or naloxone. To some,…”
Get full text

Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD) by Stark, Jennifer E., Cole, Jennifer L., Ghazarian, Rachel N., Klass, Marian J.

“…Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have delayed gastric emptying properties; however, the impact on esophagogastroduodenoscopy…”
Get full text

Impact of Proton Pump Inhibitor Use on the Effectiveness of Immune Checkpoint Inhibitors in Advanced Cancer Patients by Peng, Kangning, Chen, Ken, Teply, Benjamin A., Yee, Gary C., Farazi, Paraskevi A., Lyden, Elizabeth R.

“…Background: The gut microbiome plays a critical role in modulating the therapeutic effect of immune checkpoint inhibitors (ICIs). Proton pump inhibitors (PPIs)…”
Get full text

Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease by Schafer, Joseph H., Casey, Ashley L., Dupre, Kristina A., Staubes, Britta A.

“…Background: Because of a lack of comparative data on anticoagulant use in the advanced chronic kidney disease (CKD) population, guidelines recommend warfarin…”
Get full text

Direct Oral Anticoagulant Use in Chronic Kidney Disease and Dialysis Patients With Venous Thromboembolism: A Systematic Review of Thrombosis and Bleeding Outcomes by Cheung, Catherine Y. S., Parikh, Jash, Farrell, Ashley, Lefebvre, Melissa, Summa-Sorgini, Claudia, Battistella, Marisa

“…Objective: To evaluate how treatment with DOACs for VTE affects thrombosis and bleeding outcomes compared to warfarin in CKD and dialysis patients. Data…”
Get full text

Efficacy of Eravacycline Versus Best Previously Available Therapy for Adults With Pneumonia Due to Difficult-to-Treat Resistant (DTR) Acinetobacter baumannii by Scott, Courtney J., Zhu, Elizabeth, Jayakumar, Rebecca A., Shan, Guogen, Viswesh, Velliyur

“…Background Multidrug-resistant Acinetobacter baumannii remains challenging to treat. Although eravacycline has in vitro activity against this pathogen, there…”
Get full text

Pneumocystis jirovecii Pneumonia in the Non–HIV-Infected Population by Avino, Laura J., Naylor, Shane M., Roecker, Andrew M.

“…Objective: Summarize data on the pathophysiology, treatment, and prevention options for non–AIDS immunocompromised patients who have Pneumocystis jirovecii…”
Get full text

Antidepressant Use and Recurrent Falls in Community-Dwelling Older Adults: Findings From the Health ABC Study by Marcum, Zachary A., Perera, Subashan, Thorpe, Joshua M., Switzer, Galen E., Castle, Nicholas G., Strotmeyer, Elsa S., Simonsick, Eleanor M., Ayonayon, Hilsa N., Phillips, Caroline L., Rubin, Susan, Zucker-Levin, Audrey R., Bauer, Douglas C., Shorr, Ronald I., Kang, Yihuang, Gray, Shelly L., Hanlon, Joseph T.

“…Background: Few studies have compared the risk of recurrent falls across various antidepressant agents—using detailed dosage and duration data—among…”
Get full text

Pronounced Regional Disparities in United States Methadone Distribution by Furst, John A., Mynarski, Nicholas J., McCall, Kenneth L., Piper, Brian J.

“…Background: Methadone is an evidence-based treatment for opioid use disorder (OUD) and pain management. Methadone for OUD may be difficult for some patients to…”
Get full text

Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials by Sánchez-Rico, Marina, Rezaei, Katayoun, Lenze, Eric J., Limosin, Frédéric, Hoertel, Nicolas

Get full text

Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study by Wimmer, Barbara C., Bell, J. Simon, Fastbom, Johan, Wiese, Michael D., Johnell, Kristina

“…Objectives: To investigate whether medication regimen complexity and/or polypharmacy are associated with all-cause mortality in older people. Methods: This was…”
Get full text

Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study by Mullins, Brandon P., Kramer, C. Joseph, Bartel, Billie J., Catlin, Jennifer S., Gilder, Richard E.

“…Background: Patients often receive broad-spectrum antibiotics for nosocomial infections commonly with activity against Pseudomonas aeruginosa and…”
Get full text

Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease by Sarratt, Stefanie C., Nesbit, Ross, Moye, Robert

“…Background: Current guidelines make no specific recommendations on the selection of direct oral anticoagulants for the prevention and treatment of venous…”
Get full text

Simplification and Multidimensional Adaptation of the Stratification Tool for Pharmaceutical Care in People Living With HIV by Morillo-Verdugo, Ramón, Aguilar Pérez, Tamara, Gimeno-Gracia, Mercedes, Rodríguez-González, Carmen, Robustillo-Cortes, María de las Aguas, Robustillo-Cortes, María de las Aguas, Uranga, Aitziber Illaro, López, Alicia Lázaro, Crespo, Angels Andreu, Alarcón, Aránzazu Linares, Vega, Beatriz Proy, García, Belén López, Solanes, Carlos Seguí, Rodríguez-González, Carmen, Guisado, Carolina Aguilar, García, Elena Cárdaba, Cuadrado, Emilio Molina, Boquet, Emilio Monte, Lecha, Encarna Abad, Escrig, Esther Vicente, Orfila, Gabriel Mercadal, Aznárez, Herminia Navarro, López, Inmaculada Nacle, Orbis, Irene Cañamares, Anciano, Jara Gallardo, Arrate, Javier Casas, Ferrández, Javier Sánchez-Rubio, López, Joaquín Ignacio Serrano, Pedrosa, José Alberto Peña, González, Jose Sebastián Roldan, Lisón, Luis Carlos Fernández, Framinan, Luis Margusino, Valín, Luis Ortega, Martin, Maite, Vélez, Manuel, Crespo, María Ángeles Andreu, Maria, Maria Carmen Rosado, Coronel, María García, Fernández, Maria Jose Huertas, Gimeno-Gracia, Mercedes, García, Mercedes Manzano, Peña, Noelia Garrido, Atorrasagasti, Oihana Mora, Fenollera, Patricia Sanmartin, Ruíz, Pilar Díaz, Elcano, Ramón San Miguel, Molina, Raquel Fresquet, del Águila, Vera Áreas, Rebollo-Gómez, Dr Elena, Marfil, Dr Vanessa

“…Background People living with human immunodeficiency virus (HIV) require specific pharmaceutical care (PC). Although the 2017 Capacity-Motivation-Opportunity…”
Get full text

Exploring Safety in Gender-Affirming Hormonal Treatments: An Observational Study on Adverse Drug Events Using the Food and Drug Administration Adverse Event Reporting System Database by Gomez-Lumbreras, Ainhoa, Villa-Zapata, Lorenzo

“…Background: People with gender dysphoria are treated with hormone therapy for gender reassignment. The indication of this therapy was initially for the…”
Get full text